Table 4.
Results of vaginal cultures for six weeks after the vaginal challenge
| Antigen | Immunization route/(times) |
Percentage of mice with positive vaginal cultures and median number of C. trachomatis IFUa (range) | Total # mice that shed over 6 wks (% positive) |
|||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Week 1 | Week 2 | Week 3 | Week 4 | Weeks 5/6 | ||||||||
| Mice | IFU | Mice | IFU | Mice | IFU | Mice | IFU | Mice | IFU | |||
| rMOMP | i.vag./col. (4X) | 79 | 440,586 (<2-2,529,340) |
57 | 9,717 (<2-550,434) |
29 | <2 (<2-33,522) |
0 | <2 | 0 | <2 | 11/14 (79) |
| rMOMP | i.n./s.l. (4X) | 60 | 74,292 (<2-1,372,624) |
53 | 6 (<2-420,288) |
20 | <2 (<2-60,894) |
7 | <2 (<2-2,478) |
0 | <2 | 10/15 (67) |
| rMOMP | i.m./s.c. (4X) | 38b | <2 (<2-790,550)c |
38 | <2 (<2-126,564) |
19 | <2 (<2-1,809) |
5 | <2 (<2-16) |
0 | <2 | 9/21b (43) |
| rMOMP | i.vag./col. (2X) + i.m./s.c. (2X) |
29 b,d,e |
<2 (<2-1,610,848)c |
19 b,d |
<2 (<2-114,624)c,f,g |
10 | <2 (<2-595)f |
5 | <2 (<2-451) |
0 | <2 | 6/21b,d,e (29) |
| rMOMP | i.n./s.l. (2X) + i.m./s.c. (2X) |
19 b,d,e |
<2 (<2-2,963,620)c,f,g |
19 b,d |
<2 (<2-365,844)c,f,g |
19 | <2 (<2-287,854) |
0 | <2 | 0 | <2 | 5/21b,d,e (24) |
| MoPn | i.n. (1X) | 0 b,d,e |
<2 c,f,g |
0 b,d,e |
<2 c,f,g |
0 b,d |
<2 c,f,g |
0 | <2 | 0 | <2 | 0/15b,d,e (0) |
| Ng-rPorB | i.m./s.c. (4X) | 69 | 10,219 (<2-771,324) |
63 | 5,186 (<2-767,742) |
38 | 70 (<2-66,864) |
13 | <2 (<2-392) |
0 | <2 | 11/16 (69) |
Limit of detection: 2 IFU.
P<0.05 by the Fisher’s Exact test compared to the i.vag./col. (4X) immunization group
P<0.05 by the Mann Whitney U test compared to the i.vag./col. (4X) immunization group.
P<0.05 by the Fisher’s Exact test compared to the Ng-rPorB immunization group.
P<0.05 by the Fisher’s Exact test compared to the i.n./s.l. (4X) immunization group.
P<0.05 by the Mann Whitney U test compared to the Ng-rPorB immunization group.
P<0.05 by the Mann Whitney U test compared to the i.n./s.l. (4X) immunization group.